Delivery Order SPE2DB20D1100-SPE2DB24FC6J4
Award Date
7/9/24
Potential Completion Date
7/10/24
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,862.19, is for the delivery of Micardis HCT 40-12.5 mg tablets to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 3, 2023. The contract has no set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,663.20 delivery order contract is for the supply of Micardis HCT 80-25 mg tablets, a cardiovascular medication. The contract is a firm fixed-price, delivery order type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,283.05, is a delivery order for Micardis HCT 80-12.5 mg tablet medication with an ultimate completion date of November 13, 2023. The contract is a firm fixed-price award with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a $11,379.77 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Micardis HCT 80-12.5 mg tablets. This order was placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,854.02 firm fixed-price delivery order is for the supply of Micardis HCT 80-12.5 mg tablets, a hypertension medication, with a completion date of May 7, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Micardis HCT 80-12.5 mg tablets. The $5,652.03 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 12, 2024. The contract is not associated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,599.47, is for the delivery of Micardis HCT 80-25 mg tablet units over a period ending on January 31, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,305.28, is for the delivery of Micardis HCT 80-12.5 mg tablets to support federal healthcare programs. It is not designated as a set-aside contract. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Micardis HCT 40-12.5 mg tablets. The firm-fixed-price delivery order has a ceiling value of $2,398.33 and a completion date of December 10, 2024. The contract is not designated with a set-aside. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
The U.S. Defense Logistics Agency (DLA) has awarded a $3,358.12 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,561,813,873 units of the drug Micardis HCT 80-25 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the government to efficiently procure a...